Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments

Publisher: Bentham Science Publishers

E-ISSN: 2212-389x|4|2|130-143

ISSN: 1574-3624

Source: Current Signal Transduction Therapy, Vol.4, Iss.2, 2009-05, pp. : 130-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract